There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...
NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...
We recently published a list of Jim Cramer Was Talking About These 10 Stocks Amid Tariff Chaos. In this article, we are going ...
GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...
Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management.
Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy. Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs ...
As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results